Intravenous oxytocin in patients undergoing elective cesarean section

Area of Science:

• Obstetrics and Gynecology
• Anesthesiology
• Pharmacology

Background:

• Oxytocin is commonly used to prevent postpartum hemorrhage after cesarean delivery.
• Determining the minimal effective dose of oxytocin is crucial for optimizing patient care and resource utilization.

Purpose of the Study:

• To compare four different doses of oxytocin (5, 10, 15, and 20 IU) to identify the minimal effective dose for achieving adequate uterine tone during elective cesarean sections.

Main Methods:

• A prospective, double-blind, randomized study involving 40 healthy parturients undergoing elective cesarean section under regional anesthesia.
• Participants received varying doses of oxytocin post-umbilical cord clamping.
• Uterine tone was assessed using a linear analog scale (LAS), alongside measurements of estimated blood loss (EBL) and hematocrit changes (delta Hct).

Main Results:

• No significant differences in uterine tone were observed among the four oxytocin dose groups at any assessment interval (5, 10, 15, 20 minutes).
• Estimated blood loss and hematocrit differences were comparable across all groups.
• The study achieved 95% power to detect a 25% difference in LAS between groups at alpha = 0.05.

Conclusions:

• Administering more than 5 IU of intravenous oxytocin does not provide additional benefits regarding uterine contraction or blood loss in term parturients undergoing elective cesarean section with neuraxial anesthesia.
• A 5 IU dose of oxytocin appears to be the minimal effective dose for this patient population.